#Canada #Toronto #Vector Science #Gary Payton #Scoreboard

Strategic Partnership between Vector Science and Scoreboard

Introduction
On October 7, 2026, Vector Science and Therapeutics Corp. announced a strategic partnership with Scoreboard, Inc., co-founded by NBA Hall of Famer Gary Payton. This collaboration aims to advance the development of peptide-based products focused on enhancing athletic performance, recovery, and overall longevity. This relationship highlights the commitment of both companies to high-quality and rigorously tested wellness products tailored for athletes and active individuals.

Details of the Collaboration
Vector has made an investment in Scoreboard through a Simple Agreement for Future Equity (SAFE), a financial arrangement that allows for funding with the expectation of future equity. This partnership brings together Vector's expertise in peptide manufacturing and Scoreboard's commitment to athletic performance and wellness. The goal is to create innovative products utilizing peptides that are crucial for enhancing recovery and performance in athletic endeavors.

Vector Science is recognized for its high standards in peptide manufacturing, focusing on purity, potency, and sterility — factors that are essential for high-performance athletes who prioritize their health. The company employs advanced analytical testing to ensure that their peptides meet these stringent requirements, thus ensuring that they offer only the best products to consumers.

The Importance of Peptides in Sports Medicine
Peptides have gained attention in the sports medicine domain due to their roles in muscle repair, recovery, and enhancing physical performance. However, these compounds can be unstable when in liquid or gel forms, which has historically limited their use in consumer products. Vector Science addresses this challenge with its proprietary delivery technology, allowing for stability and efficacy in various formulations.

Vector's intellectual property portfolio encompasses multiple innovations in peptide delivery, including multi-route delivery systems and advanced transdermal methods. By harnessing this expertise, the companies aim to develop Scoreboard products that maintain peptide potency while enhancing their usability across different formats. This aligns with Gary Payton's vision for Scoreboard to cater to both professional athletes and everyday individuals pursuing better health and performance outcomes.

Quotes from Leadership
Bill Jackson, CEO of Vector Science and Therapeutics, stated, "Performance, recovery, and longevity are rapidly evolving areas of wellness, and peptide innovation has an important role to play in that growth. Our relationship with Scoreboard creates an opportunity to bring our focus on quality and safety into products designed for everyday athletes and high performers. We look forward to working with the Scoreboard team and helping bring these products to market."

Gary Payton, reflecting on his experience in professional sports, emphasized the significance of recovery in an athlete's regimen. He commented, "I've spent my life around performance, and I know recovery is just as important as the work you put in. Working with Vector brings science and innovation into that vision, and I'm excited about what we can create together."

Payton II, another participant from the duo, echoed these sentiments by noting the seriousness with which they approach product quality. He remarked, "Working with Vector gives Scoreboard a partner that takes testing and standards as seriously as we do."

Conclusion
As the landscape of sports medicine and wellness continues to evolve, the partnership between Vector Science and Scoreboard exemplifies a commitment to innovation, quality, and athlete well-being. This collaboration promises to deliver cutting-edge products that integrate the latest scientific advances, setting a new standard in the wellness sector for athletes and health-conscious individuals alike. Vector Science, headquartered in Mequon, Wisconsin, remains at the forefront of this initiative, with a steadfast dedication to enhancing the quality of life through advanced medical technologies.

About Vector Science and Therapeutics Corp.
Vector Science focuses on pioneering drug delivery technologies and high-quality peptide manufacturing, compliant with all regulations for pharmaceutical use. Their offerings target the fields of sports medicine, regenerative medicine, and pain management, making significant strides to enhance patient outcomes.

About Scoreboard
Scoreboard is dedicated to developing wellness products for high performers and everyday individuals, focusing on recovery and longevity by integrating scientific insights and advanced formulations. As they embark on this exciting new chapter with Vector, the potential for innovative solutions seems boundless.